Results
The authors included 12 randomized controlled trials for analysis, with 828 patients. Five trials compared nonsteroidal antiinflammatory drugs versus placebo, 4 compared nonsteroidal anti-inflammatory drugs versus opioids, and 4 compared nonsteroidal anti-inflammatory drugs versus spasmolytic drugs (one study compared nonsteroidal anti-inflammatory drugs with both opioids and spasmolytic drugs). The authors determined all but one trial comparing nonsteroidal anti-inflammatory drugs versus placebo to be at low risk for bias.
The ages of the patients in the included studies ranged from 18 to 86 years. All patients underwent treatment in an emergency department (ED) setting. There was limited representation of elderly patients and patients with comorbidities in the included studies. Most studies excluded patients with comorbidities such as renal disease, heart disease, and diabetes. Similarly, all but one study (comprising 53 patients) excluded patients older than 65 years. Nearly all studies excluded patients with acute cholecystitis, pancreatitis, and peptic ulcer disease because of potential complications with nonsteroidal anti-inflammatory drugs. There were no serious adverse events in any of the included trials. Quality of evidence based on the Grading of Recommendations Assessment, Development and Evaluation was moderate for nonsteroidal antiinflammatory drugs versus placebo, 
Commentary
Cholelithiasis affects more than 20 million adults in the United States, with gallstones present in up to 20% of healthy adults by aged 40 years. [3] [4] [5] Biliary colic is the most common manifestation of gallstones, occurring in 5.5% to 15.4% of patients with gallstones. 6, 7 The literature indicates that more than one third of patients presenting to an ED with biliary colic and not undergoing cholecystectomy are likely to return to the ED within 2 years for gallstone-related symptoms. 8 Nonsteroidal anti-inflammatory drugs may also reduce the frequency of short-term complications, including mild cholecystitis, jaundice, cholangitis, and pancreatitis, although this requires further study. 9 Emergency physicians require effective tools for providing pain control for these patients.
This
meta-analysis provides compelling evidence that nonsteroidal anti-inflammatory drugs outperform placebo in relieving pain associated with this disorder and provide pain relief comparable to that with opioids. The specific agents demonstrated to have efficacy by these studies include intravenous diclofenac 50 to 75 mg and intravenous ketoprofen 200 mg. Finally, this meta-analysis suggests nonsteroidal anti-inflammatory drugs may provide pain relief superior to that with spasmolytics (tenoxicam and hyoscine butylbromide), but there is a need for additional high-quality studies comparing these agents.
Taken together, these results support the use of nonsteroidal anti-inflammatory drugs as an analgesic in patients presenting to the ED with biliary colic. Nonsteroidal anti-inflammatory drugs provide greater pain relief than placebo, and although not yet formally confirmed by noninferiority trials, nonsteroidal antiinflammatory drug pain relief is likely comparable to that provided by opioids and may reduce the need for opioids. These results do not apply to patients excluded from the studies in this metaanalysis, including those older than 65 years or with comorbidities. These results similarly do not apply to patients with suspected or confirmed peptic ulcer disease or gastritis, in whom nonsteroidal anti-inflammatory drugs may increase the risk of bleeding. Similarly, emergency physicians should avoid nonsteroidal antiinflammatory drugs for patients with presentations suggestive of acute cholecystitis (eg, febrile or positive Murphy's sign) because their antiplatelet effect may complicate surgical intervention. For these patients, emergency physicians should use other medications. Future literature would benefit from studies of oral nonsteroidal anti-inflammatory drugs in biliary colic to ascertain whether these results depend on route of administration, as well as applicability in elderly patients. 
